Opioid overdoses have reached epidemic proportions. While the best solution would be to prevent opioid overdoses in the first place, an important piece in the effort to reduce these fatalities is to have a good way of preventing overdoses from leading to death. That’s where the opioid antagonist naloxone (Narcan) comes in.

David A. Frenz, MD discusses inpatient detox for alcohol, and the approaches used for determining the right therapies.

It’s often assumed that most excessive drinkers are alcohol dependent, but this is not necessarily the case.

Your typical patient with a gambling disorder may not fit yesterday’s stereotype.

First approved in 2002, Suboxone, a sublingual pill, was undoubtedly a breakthrough in opiate addiction treatment—especially as compared to methadone. Unlike methadone, Suboxone could be prescribed in the office and filled at pharmacies, freeing patients from the shackles of the methodone lifestyle and its required daily clinic visits.

A new study provides strong evidence that chronic marijuana use during adolescence can lead to significant social and psychiatric issues later in life.

Today’s conversation about “smart drugs” is fundamentally different and refers to the use of medications by people without psychiatric disorders who seek a boost or cognitive edge.

Find out more about how you can evaluate and treat ADHD symptoms in patients with addiction, in an interview with clinical neuropsychologist Christopher B. Mertz.

Buprenorphine (Suboxone and others) is an effective medication for treating patients with opioid addiction. Research has shown that it works better than standard psychosocial or “abstinence-based” treatments. But is the cost of the drug worth the extra therapeutic benefit?

New technology has brought with it a new addiction. Clinicians may now face the challenge of how to treat the growing problem of internet addiction, where patients experience online-related, compulsive behaviors that interfere with daily life, work, and relationships.